Ovarian Damage During Chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility

Women with autoimmune diseases such as lupus, scleroderma, and vasculitis receiving cyclophosphamide for severe disease manifestations risk primary ovarian insufficiency (POI) due to gonadotoxicity of this therapy. In addition to loss of reproductive potential, POI is associated with increased risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Marder, Wendy, Fisseha, Senait, Ganser, Martha A., Somers, Emily C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747568/
https://www.ncbi.nlm.nih.gov/pubmed/23970822
http://dx.doi.org/10.4137/CMRH.S10415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747568/
https://www.ncbi.nlm.nih.gov/pubmed/23970822
http://dx.doi.org/10.4137/CMRH.S10415

Ejemplares similares